ð»ââïžâš ããããŸã®ããããããå€ããããè¬åº§ âšð»ââïž
äžã®äžã«ã¯ãåžžèãã®è¡£ããŸãšã£ããŸãŸãäœå幎ãä¿¡ãããç¶ããŠããå¥åº·æ å ±ãããããããã®ãããïŸïœ«ïŸïœ«ã
ãæé žçŽ éåããããšæŽ»æ§é žçŽ ãåºãŠäœã«æªããããã¿ãã³Cããã£ã·ãæãã°ãã¬ãŒãã³ã°å¹æãäžããããã¯ã¬ã¢ãã³ã¯ãããã§ã®é£²ããã®ãããµããªãå±±ã»ã©é£²ãã°èåãé²ãããââãã¬ããäžåºŠã¯èããããšãããã®ã§ã¯ãªããã®ïŒ
ãšããããè¿å¹Žã®LongevityïŒé·å¯¿ç§åŠïŒç ç©¶ã¯ãããããåžžèããæ¬¡ã ãšã²ã£ããè¿ããŠããã®ãããããããã¬ãã®å¥åº·çªçµã¬ãã«ã®è©±ã§ã¯ãªããæ»èªä»ãåŠè¡èªã§çºè¡šãããå³å¯ãªç ç©¶ã«åºã¥ããŠãããã
ð§žãããããŸã¡ããããããã¿ãã³Cãé广ã£ãŠã©ãããããšâŠïŒ å¥åº·ã«ããã£ãŠåŠæ ¡ã§ç¿ã£ããã ãã©âŠã
ð»ââïžãïŸïœ¯ïŸïœ°ãããã£ãããã¿ãã³Cã”æªã”ã®ã§ã¯ãªãã®ããããã¿ãã³Cã®”æãæ¹ãšã¿ã€ãã³ã°”ãåé¡ãªã®ãããããã®èšäºã§ã¯ãLongevityç§åŠãæããŠããã”åžžèã®ã¢ããããŒã”ã7ã€ããã£ããè£ä»ããšãšãã«ãäŒãããããð»ââïžã£ïŸïŸïœŒïœ¯ã
âïžð¥ åžžèâ ãæé žçŽ éåã§æŽ»æ§é žçŽ ãåºã â äœã«æªããâ éããïŒ
ããã¯1990幎代ãã2000幎代ååã«ãããŠåºãä¿¡ããããŠãããããªãŒã©ãžã«ã«èª¬ãã®åæ®ãªã®ããããéåãããšããããé žçŽ ãåžã â æŽ»æ§é žçŽ çš®ïŒROSïŒãå¢ãã â 现èãå·ã€ã â ã ããæ¿ããéåã¯äœã«æªãããšããäžæ®µè«æ³ããŸããšãããã«åºãŸã£ãã®ããã
ãšãããããããã®åžžèã¯ããå®å šã«ã¢ããããŒããããŠããã®ããã
2005幎ã«RadakããåŠè¡èªãBiogerontologyãã«çºè¡šããç»æçãªè«æã§ããéåãã«ãã·ã¹ããšããæŠå¿µãåããŠæå±ãããã®ããããã«ãã·ã¹ãšã¯äœãïŒ æ¬æ¥ãªãæå®³ãªç©è³ªã§ããäœçšéã§ããã°ããã£ãŠäœã«ãšã£ãŠæçãªé©å¿åå¿ãåŒãèµ·ãããšããçç©åŠççŸè±¡ã®ããšãããæ¯èã®æ¯ããè§£æ¯å€ãäœããããªãã®ãšæãã°ããããã
ð§žãããæŽ»æ§é žçŽ ã£ãŠ”æ¯”ãããªã㊔信巔ã£ãŠããšïŒã
ð»ââïžããŸãã«ãã®éããªã®ããïŒ éåã«ãã£ãŠçèã®äžã§é©åºŠã«çºçããROSã¯ãäœã«”ãã£ãšå®ããåºãããšããã·ã°ãã«ãéã圹å²ãæãããŠããã®ããããã®ä¿¡å·ãåããŠãäœå ã®æé žåé µçŽ ïŒSODãã°ã«ã¿ããªã³ãã«ãªãã·ããŒãŒãªã©ïŒã®ç£çãå¢ããDNAä¿®åŸ©é µçŽ ãæŽ»æ§åããã¿ã³ãã¯è³ªåè§£é µçŽ ãèªå°ããããçµæãšããŠãé žåã¹ãã¬ã¹é¢é£çŸæ£ã®ãªã¹ã¯ãäžãããèåããã»ã¹ãé å»¶ããã®ãããã
ããã¯ããã«åã«ãŒããã§çè§£ããã®ãäžçªããããããã®ããã2020幎ã«PMCã«æ²èŒãããPowersãã®å æ¬çã¬ãã¥ãŒã詳ãã解説ããŠããããæšªè»žã«ROSç£çéã瞊軞ã«ççåŠçæ©èœããšããšãçŸãããã«åã®ã«ãŒããæãã®ãããäœãäžçšåºŠã®ROSç£çã¯æ©èœãé«ããæé©ã¬ãã«ãè¶ ãããšä»åºŠã¯ãã¡ãŒãžã«è»¢ãããã€ãŸããå€ãããŠããã¡ããŒãã§ããã¡ãã¡ããã©ããéãæåŒ·ããªã®ããã
ð§žãããããéåããªãã§ãã£ãšããŠãã»ããæŽ»æ§é žçŽ ãå°ãªããŠå®å šâŠã£ãŠã®ã¯å€§ééããªãã ã
ð»ââïžãïŸïœ«ïŸïœ«ããããéã§ãªãç ç©¶è ãã¡ã¯”人éã¯ããããäžæŽ»åã§ããããã«ã¯èšèšãããŠããªã”ãšãŸã§èšãåã£ãŠãããããéåäžè¶³ã«ãã£ãŠååã¬ãã«ã®ã·ã°ããªã³ã°çµè·¯ãé»å®³ãããé žåã¹ãã¬ã¹é¢é£çŸæ£ã®çºçãªã¹ã¯ãããã£ãŠäžæããã®ãããã€ãŸããåããªãããšèªäœãé žåã¹ãã¬ã¹ãå¢å€§ããããªã¹ã¯å åãªã®ãããð»ââïžã£ïŸïŸïœŒïœ¯ã
ãããŠããã²ãšã€éèŠãªããšãããã®ããã嫿°æ§éåïŒã¹ããªã³ããééæããªã©ïŒãæé žçŽ éåãšåçšåºŠã®é žåã¹ãã¬ã¹ãçãããããšãè€æ°ã®ç ç©¶ã§ç¢ºèªãããŠããã®ãããã€ãŸããæé žçŽ éåã ããæŽ»æ§é žçŽ ãåºãããšããåæãã®ãã®ã誀ããªã®ãããæé žçŽ ãçãã¬ããé©åºŠã«ããã°ã©ã¡ããROSã·ã°ãã«ãéããé©å¿åå¿ãåŒãåºãããšãã§ããã®ãããã
ãã ããé©åºŠã«ããéµããã24æéã®ãŠã«ãã©ãšã³ãã¥ã©ã³ã¹éåã®ãããªæ¥µç«¯ãªæä¹ éåã§ã¯ãçèããåé¢ããããã³ã³ããªã¢ã®HâOâïŒéé žåæ°ŽçŽ ïŒç£çéã73%ãå¢å ãã28æéã®å埩åŸã«ããããå ã«æ»ã£ããšããå ±åãããã®ããããã«ãã·ã¹ã®æ©æµãåããã®ã¯äœãäžåŒ·åºŠã®ç¯å²ã§ãã£ãŠãæ ¢æ§çãªé床ã®éåã¯ãã«åã«ãŒãã®å³åŽãã€ãŸããã¡ãŒãžãŸãŒã³ã«çªå ¥ããŠããŸãã®ããã
ð§žããã©ãœã³ã®èµ°ããããšããæ¯æ¥äœæéãããŒãã«ããã®ã¯ãã¡ã£ãŠããšãã
ð»ââïžãããããããšãããLongevityã®èŠç¹ã§ã¯”ãŸãŒã³2ïŒäŒè©±ã§ãããããã®åŒ·åºŠïŒã®æé žçŽ ”ãš”é±2ã3åã®çã㬔ã軞ã«ãããŸã«HIITïŒé«åŒ·åºŠã€ã³ã¿ãŒãã«ãã¬ãŒãã³ã°ïŒãå ¥ããçšåºŠãæé©ãã©ã³ã¹ãªã®ãããããããã¯ãã«ãã·ã¹ã®ãã«åã«ãŒãã®é ç¹ãè¶ ããŠããŸããéã«è¶³ããªãããã¯é©å¿åºæ¿ãå ¥ããªãããã®”ã¡ããã©ãã”ã®ã¹ã€ãŒãã¹ããããçãã®ãLongevityãã¬ãŒãã³ã°ã®çé«ãªã®ãããâšã
âïžð åžžèâ¡ããã¿ãã³Cã»Eãããããæãã°éå广ãé«ãŸããâ éããïŒæãããã¯å¹æãæã¡æ¶ãïŒ
ããã¯åžžèâ ã®ãã«ãã·ã¹çè«ãšçŽçµãããè¡æçãªç ç©¶çµæãªã®ããã
2014幎ã«PaulsenããåŠè¡èªãThe Journal of Physiologyãã«çºè¡šããäºéç²æ€ã©ã³ãã 忝èŒè©ŠéšïŒn=54ïŒã®çµæã¯ããã£ãããã¹æ¥çã«æ¿éãèµ°ãããã®ããã11é±éã®æä¹ åãã¬ãŒãã³ã°ã®ååŸã«ãã¿ãã³CïŒ1000mg/æ¥ïŒãšãã¿ãã³EïŒ400IU/æ¥ïŒãæåãããã°ã«ãŒããšããã©ã»ãïŒåœè¬ïŒã°ã«ãŒããæ¯èŒãããšããããã¿ãã³CïŒEã°ã«ãŒãã§ã¯ããã³ã³ããªã¢ã¿ã³ãã¯è³ªCOX4ã®å¢å ãæå¶ãããã®ããã
ð§žããâŠãã¿ãã³CãšEã飲ãã ã»ããçèã®é©å¿ãéã£ãã£ãŠããšïŒïŒã
ð»ââïžããã®éããªã®ãããã¡ã«ããºã ã¯ãããããéåã§çããROSãçèã«”é©å¿ãããšããã·ã°ãã«ãéãã®ãããã倧éã®ãã¿ãã³CãšEããã®ã·ã°ãã«ãæ¶ããŠããŸãã®ãããç«çœå ±ç¥åšã鳎ã£ãŠããã®ã«ãå ±ç¥åšã®ã¹ã€ãããåã£ãŠããŸããããªãã®ã¢ãã®ãç«äºïŒé žåã¹ãã¬ã¹ïŒã¯ç¢ºãã«åãŸã£ãããã«èŠããããé¿é£èšç·ŽïŒé©å¿åå¿ïŒããã£ã³ã»ã«ãããŠããŸãã®ããã
åç©å®éšã§ã¯ããã«æç¢ºãªçµæãåºãŠããã®ãããã©ããã«ãã¿ãã³Cãæäžããªãããã¬ãŒãã³ã°ããããšãããããã³ã³ããªã¢æ°çã®åžä»€å¡ã§ããPGC-1αã®ã¿ã³ãã¯è³ªã¬ãã«ãå¢å ããªãã£ãã®ããããã©ã»ã矀ã§ã¯æ£åžžã«PGC-1αãå¢å ããããã³ã³ããªã¢ãã€ãªãžã§ãã·ã¹ã®ããŒã«ãŒã§ããã·ãã¯ãã cãå¢å ããã«ãããããããããã
ããã«2022幎ã®äºéç²æ€RCTã§ã¯ã10é±éã®ã¬ãžã¹ã¿ã³ã¹ãã¬ãŒãã³ã°äžã«ãã¿ãã³CïŒEãæåããã°ã«ãŒãã§ãäžå身ã®çåãšçè¥å€§ã®é©å¿ãéåããåŸåã確èªãããã®ãããã€ãŸããæé žåãµããªã®æãããã¯æä¹ åã ãã§ãªãçåãã¬ãŒãã³ã°ã®å¹æã«ã圱é¿ãåŸããšããããšããã
ð§žãããããã¿ãã³Cã¯é£²ãŸãªãã»ããããã®ïŒã
ð»ââïžãããã倧äºãªãã€ã³ãããããã¿ãã³Cèªäœãæªãã®ã§ã¯ãªãã”é«çšéã®ãµããªãéåã®ååŸã«æã”ã®ãåé¡ãªã®ãããé£äºããèªç¶ã«æåããéã®ãã¿ãã³Cã¯äœãåé¡ãªããæç©ãéèããã£ããé£ã¹ãåã«ã¯ããã«ãã·ã¹åå¿ãéªéããã»ã©ã®éã«ã¯ãªããªãã®ããããããé·æçãªãã¿ãã³Cäžè¶³ã®ã»ããã¯ããã«ãŸãããããåé¡ã¯ãµããªã§1000mg以äžãäžæ°ã«æããããªéå°æåããéåã®ã¿ã€ãã³ã°ã«åãããŠè¡ãããšãªã®ãããã
2017幎ã«Radakããçºè¡šããè«æã§ã¯ããã«è峿·±ã仮説ãæç€ºãããŠããã®ãããæé žåãµããªã®å¹æã¯ãã¿ã€ãã³ã°ãã«ãã£ãŠæ£å察ã«ãªãåŸããšãããã®ããããã«ãã·ã¹ã«ãŒãã®é ç¹ã«éããåã«æé žåç©è³ªãæäžãããšé©å¿ãæžåŒ±ãããããé ç¹ãè¶ ããåŸïŒã€ãŸãé床ãªé žåã¹ãã¬ã¹ãçããŠããç¶æ³ïŒã§æäžããã°éã«æçã«åããšããäºé¢æ§ãããã®ããã
ð§žãã¿ã€ãã³ã°ã§è¬ã«ãæ¯ã«ããªããã âŠãããâŠã
ð»ââïžãããããã®ã”ãšãããããã¿ãã³å€ã飲ãã§ããã°å®å¿”ãšããæä»£ã¯ããçµãã£ãã®ãããLongevityçã«æ£ããçãã¯ã”ãµããªãããå ã«é£äºãæŽãã”ãªã®ãããð»ââïžã£ïŸïŸïœŒïœ¯ã
âïžðª åžžèâ¢ããµããªã¯å±±ã»ã©é£²ãã¹ããâ ãããã€ã³ãšã¯ã¬ã¢ãã³ã ãã§OKïŒ
ååã®Longevityèšäºã§ç޹ä»ãããã£ãããã¹ã®å°éå®¶ããåºæ¬ãµããªã¯ã¯ã¬ã¢ãã³ãšãããã€ã³ã ãããšè¿°ã¹ãŠãã£ãã®ããããããã¯å®ã¯Longevityç ç©¶ã®ãšããã³ã¹ããŒã¹ã§èŠããšãããªãçãå°ã䞻匵ãªã®ããã
ãŸããããã€ã³ã«ã€ããŠãããçèã®ç¶æã¯Longevityã®12ã®èšåºã¢ãããŒãã®ã²ãšã€ãçåãšçèãã«çŽçµããŠããã®ããããµã«ã³ããã¢ïŒå 霢æ§çéæžå°ïŒã®äºé²ã«ã¯ã¬ãžã¹ã¿ã³ã¹ãã¬ãŒãã³ã°ãšååãªã¿ã³ãã¯è³ªæåãäžå¯æ¬ ã§ãäœé1kgããã1.2ã2.0gã®ã¿ã³ãã¯è³ªæåãæšå¥šãããŠããã®ãããé£äºã ãã§ãã®éã確ä¿ããã®ãé£ãã人ã«ãšã£ãŠããããã€ã³ããŠããŒã¯ã³ã¹ãã®ããè£å©ããŒã«ãªã®ããã
ãããŠã¯ã¬ã¢ãã³ããããLongevityæèã§ç¹ã«é¢çœã話ãªã®ããã
ð§žãã¯ã¬ã¢ãã³ã£ãŠããã£ãã«ããŒãçèããã³ããããããã«é£²ããã€ãããªãã®ïŒã
ð»ââïžãïŸïœ«ïŸïœ«ãããã£ãããããå€ãåžžèãããã¯ã¬ã¢ãã³ã¯ãã¯ã”çèã®ããã ãã®ãµã㪔ã§ã¯ãªãã®ãããã2025幎ã®å æ¬çã¬ãã¥ãŒè«æã®ã¿ã€ãã«ã¯ãã°ã”Creatine for Life”ââ”人çã®ããã®ã¯ã¬ã¢ãã³”ããïŒã
2025幎7æã«TandfonlineïŒTaylor & FrancisïŒã§çºè¡šãããææ°ã®ãã©ãã£ãã¬ãã¥ãŒã§ã¯ãã¯ã¬ã¢ãã³ã»ã¢ããã€ãã¬ãŒãïŒCrMïŒã®å¹æãçèã ãã§ãªãã骚ãèªç¥æ©èœã転åäºé²ãè¡ç³åæ ã«ãŸã§åã¶ããšã瀺ãããŠããã®ãããäž»ãªç¥èŠãæŽçãããšããŸãçèãšéªšã«ã€ããŠã¯ãéåãšäœµçšããããšã§å šèº«ã®é€èèªäœéãçãµã€ãºãçåã骚é¢ç©ã»éªšåã®æ¹åã確èªãããŠãããæ¬¡ã«èªç¥æ©èœã«ã€ããŠãã¯ã¬ã¢ãã³ã¯è¡æ¶²è³é¢éãééã§ããã®ãããè霢ããŠã¹ã«æäžãããšãããè³å ã®æŽ»æ§é žçŽ ãæžå°ããèåè²çŽ ãªããã¹ãã³ãæžå°ããç¥çµæé·ã»ç¥çµä¿è·ã»åŠç¿ã«é¢é£ããéºäŒåã®çºçŸãäžæããã®ãããããã«2025幎ã®ã¢ã«ããã€ããŒç ãã€ããã詊éšã§ã¯ãã¯ã¬ã¢ãã³20g/æ¥ã®æäžã§è³å ã¯ã¬ã¢ãã³æ¿åºŠã11%äžæãããšããå ±åãããããããããŠ2025幎ã®ã·ã¹ãããã£ãã¯ã¬ãã¥ãŒïŒã¡ã¿ã¢ããªã·ã¹ïŒ16ä»¶ã®RCTãn=492ïŒã§ã¯ãã¯ã¬ã¢ãã³è£å ã§èšæ¶åãæ³šææç¶æéãæ å ±åŠçéåºŠã«ææãªæ¹åã確èªãããã®ããã
ð§žããããïŒ è³ã«ãå¹ãã®ïŒïŒã
ð»ââïžããããªã®ãããã¯ã¬ã¢ãã³ãããŒãŒïŒCKïŒã·ã¹ãã ã¯çްèã®ãšãã«ã®ãŒä»£è¬ã®å¹çãæé©åããä»çµã¿ã§ãçèã ãã§ãªãè³ãå«ããã¹ãŠã®ãšãã«ã®ãŒéèŠã®é«ãçµç¹ã§éèŠãªåœ¹å²ãæãããŠããã®ããããããŠå 霢ãšãšãã«ãã®CKã·ã¹ãã ã®å¹çãèœã¡ãŠãããå€ããã¯ã¬ã¢ãã³ãè£å ããããšã§ããšãã«ã®ãŒäŸçµŠã®åºäžããšé žåã¹ãã¬ã¹ã®è»œæžãåæã«å³ããå¯èœæ§ãããã®ãããã
ããã«è霢ããŠã¹ã䜿ã£ã2025幎ã®ç ç©¶ã§ã¯ãé·æã¯ã¬ã¢ãã³è£å ãD-ã¬ã©ã¯ããŒã¹èªçºèåã¢ãã«ã«ãããŠèªç¥æ©èœãšæµ·éŠ¬ã®æ§é çå¯å¡æ§ãæ¹åãããã®æ©åºãšããŠè³åã¯ã¬ã¢ãã³ãããŒãŒïŒCK-BBïŒæŽ»æ§ã®å¢å ãé¢äžããŠããããšã瀺ãããã®ããã
ð§žãã§ãããŒãã³ãœã³ç ãšãALSã®å€§èŠæš¡è©Šéšã§ã¯å¹ããªãã£ãã£ãŠâŠã
ð»ââïžãéãã®ãããã£ã確ãã«ããŒãã³ãœã³ç ãALSã®å€§èŠæš¡é·æè©Šéšã§ã¯ã¯ã¬ã¢ãã³ã®æç¢ºãªèšåºçæå¹æ§ã¯ç¢ºèªãããªãã£ãã®ãããããã¯æ£çŽã«èšã£ãŠãããã°ãªãã¬ç¹ããããã ããäºé²ãšæ²»çã¯å¥ç©ãªã®ããããã§ã«é²è¡ããç¥çµå€æ§çŸæ£ãé転ãããã®ã¯å°é£ããããå¥åº·ãªç¶æ ããã®äºé²çè£å ã«ããèªç¥æ©èœç¶æã«ã¯äŸç¶ãšããŠããžãã£ããªãšããã³ã¹ãããã®ãããããã¯ãŸã ç ç©¶éäžã§ãæå®ã¯é¿ããã¹ãããããæ¹åæ§ã¯ææãšèšã£ãŠããããã
ã€ãŸãLongevityèŠç¹ã§ã®ãµããªã¡ã³ãæé©è§£ã¯ãå±±ã»ã©ã®çš®é¡ã飲ãããšã§ã¯ãªãããšããã³ã¹ã®è³ªãé«ãå°æ°ã®ãµããªãæ£ãã䜿ãããšãªã®ããããããã€ã³ã§çã¿ã³ãã¯åæãæ¯ããã¯ã¬ã¢ãã³ã§ãšãã«ã®ãŒä»£è¬ãšç¥çµä¿è·ãåºäžãããããã®2æ¬æ±ã«ãé£äºããååãªãã¿ãã³ã»ããã©ã«ãæåãããšããåœããåã®åå°ãå ããã°ããããLongevityãµããªæŠç¥ã®æ žå¿ãªã®ãããã
âïžð åžžèâ£ããã£ãšããŒãã«ããã£ãšé·ãèµ°ãã°å¥åº·ã«ãªããâ éããïŒ Less is More
åé ã®æŽ»æ§é žçŽ ãã«ãã·ã¹ã®è©±ãšç¹ããã®ããããLongevityèŠç¹ã®ãã¬ãŒãã³ã°ã¯ãæå€§ããã©ãŒãã³ã¹ã®è¿œæ±ããšã¯æ¹åæ§ãçéãªã®ããã
äžåŒ·åºŠã®æä¹ åãã¬ãŒãã³ã°ãç¶ç¶çã«è¡ããšãäœå ã®SODïŒã¹ãŒããŒãªãã·ããã£ã¹ã ã¿ãŒãŒïŒæŽ»æ§ãææã«äžæããæ¥æ§ã®äžãé«åŒ·åºŠéåã«ããé žåãã¡ãŒãžã軜æžãããããšãç ç©¶ã§ç€ºãããŠããã®ãããã€ãŸããæ®æ®µããã»ã©ã»ã©ã«éããŠãã人ã®äœã¯ãæ¥ãªã¹ãã¬ã¹ã«å¯ŸããŠãèæ§ãé«ãããšããããšããã
äžæ¹ã§ããã¬ãŒãã³ã°ãç©ãã§ããªã人ãçªç¶æ¿ããéåããããšãé žåã¹ãã¬ã¹ãææã«äžæããçæå·ã奜äžçã®æŽ»æ§åãççãçèçãåŒãèµ·ããããã®ããã
ð§žã鱿«ã ãäžæ°ã«ãžã è¡ã£ãŠã¬ã³ã¬ã³ããã®ã¯é广ãªãã âŠã
ð»ââïžããã®éãããã”鱿«ã ãæŠå£«”ãããã”æ¯æ¥ã¡ãã£ãšãã€åãå µå£«”ã®ã»ããLongevityçã«ã¯ãã£ãšåªç§ãªã®ããããã£ãããã¹ã¬ãã«ãé«ã人ã»ã©é žåã¹ãã¬ã¹ãžã®èæ§ãé«ããšããç¥èŠã¯ã”ç¶ç¶ã¯åãªã”ã®ååçç©åŠçãªè£ä»ãã§ãããã®ãããð»ââïžã£ïŸïŸïœŒïœ¯ã
âïžð§¬ åžžèâ€ã掻æ§é žçŽ ã¯èåã®”åå ”ãâ æ£ç¢ºã«ã¯”ã·ã°ãã«åå”ã§ããã
ããªãŒã©ãžã«ã«èª¬ïŒæŽ»æ§é žçŽ èå仮説ïŒã¯1956幎ã«Harmanãæå±ããç±ç·ããçè«ã§ãäœå幎ãèåç ç©¶ã®äžå¿ã«ãã£ãã®ãããããã2023幎ã®López-OtÃnãã®æ¹èšHallmarks of Agingè«æã§ã¯ãããã³ã³ããªã¢æ©èœéå®³ã®æèã§ROSã®äœçœ®ã¥ãã倧ããä¿®æ£ãããŠããã®ããã
è¥ãææã®ããã³ã³ããªã¢ã¹ãã¬ã¹ã¯ROSãä»ããŠããããã«ãã·ã¹ããåŒãèµ·ããã现èã®é©å¿åãšçåèœåãé«ããã®ããããããå 霢ã«ãã£ãŠããã³ã³ããªã¢ã®å質管çïŒãããã¡ãžãŒïŒãäœäžãããšãROSã®ãã©ã³ã¹ã厩ããæ ¢æ§çãªé žåã¹ãã¬ã¹ã«è»¢ããã®ããã
ã€ãŸãROSã¯ãåå ãã§ã¯ãªãã調ç¯å åãã§ãããåé¡ã¯”ROSãã®ãã®ã®ååš”ã§ã¯ãªã”ROSã®éãšã¿ã€ãã³ã°ãšé€å»èœåã®ãã©ã³ã¹ã®åީ壔ãªã®ããã
ð§žããããæŽ»æ§é žçŽ ãå®å šã«æ¶ãå»ãããšããæé žåãµããªã®å€§éæåã¯ããã©ã³ã¹ãå£ãã£ãŠããšã ãã
ð»ââïžãïŸïœ«ïŸïœ«ãããã£ãããã¬ãã¯ãã®èšäºã®æ žå¿ãèŠäºã«èšèªåããŠããããããåžžèâ ããâ€ãŸã§ãã¹ãŠç¹ãã£ãŠããã®ãããROSã¯æµã§ã¯ãªããäœå ã®é²è¡èšç·Žã®å·ä»€ä¿ãããå·ä»€ä¿ãæ¶ããŠããŸã£ãããããæ¬åœã®è åšãæ¥ããšãã«å¯Ÿå¿ã§ããªããªãã®ãããâšã
âïžð¥Š åžžèâ¥ãæé žåé£åãããããé£ã¹ãã°èåãé²ãããâ é£äºããã¯âããµããªããã¯â³
ãããŸã§ã®è©±ãèããšããããæé žåé£åãé£ã¹ãªãã»ããããã®ïŒããšæã£ãŠããŸãããããã¬ããããã¯éãã®ããã
ç ç©¶è ãã¡ãåé¡èŠããŠããã®ã¯ããµããªã¡ã³ããšããŠé«çšéã®åäžæé žåç©è³ªãæåããããšãã§ãã£ãŠããæç©ãéèã«å«ãŸããå€çš®å€æ§ãªåŸ®éã®æé žåç©è³ªãé£äºãšããŠæãããšãã§ã¯ãªãã®ãããé£åäžã®æé žåç©è³ªã¯éãç©ããã§ããã€æ°çŸçš®é¡ã®ããªãã§ããŒã«ãã«ãããã€ããè€åçã«åããããåäžãµããªã®ãã㪔ã·ã°ãã«é®æ”广ã¯çãã«ããã®ããã
è€æ°ã®ç ç©¶ã¬ãã¥ãŒããæç©ãéèãéããæé žåç©è³ªã®æåã¯ãµããªã¡ã³ãã«ãããããããé©åã§ããããšçµè«ã¥ããŠããããã
ð§žããµããªãé£äºãã§å šç¶éããã ããåããã¿ãã³Cã§ããªã¬ã³ãžããæãã®ãšãµããªã§1000mgæãã®ã¯å¥ç©ãªãã ã
ð»ââïžããã®éãããããªã¬ã³ãžã«ã¯ãã¿ãã³Cã ãã§ãªããé£ç©ç¹ç¶ããã©ããã€ããã«ãªãŠã ãæ°Žåãªã©ãå«ãŸããŠãããäœã¯ããããè€åæ é€çŽ ã®ããã±ãŒãžãšããŠé²åçã«é©å¿ããŠããã®ããããµããªã¯èšãã°”æåã ããæœåºãã謔ã§ãã£ãŠãé£åã®ä»£æ¿ã«ã¯ãªãã¬ã®ãããð»ââïžã£ïŸïŸïœŒïœ¯ã
âïžð§ åžžèâŠãã¯ã¬ã¢ãã³ã¯è èã«æªããâ å¥åº·ãªäººã«ã¯åé¡ãªãããããæ©æµãå€ã
ã¯ã¬ã¢ãã³ã«å¯Ÿããããã²ãšã€ã®æ ¹åŒ·ã誀解ããè èã«æªãããšãããã®ãããããã¯ã¯ã¬ã¢ãã³ã®ä»£è¬ç£ç©ã§ããã¯ã¬ã¢ããã³ãè æ©èœã®ææšãšããŠäœ¿ãããŠããããããã¯ã¬ã¢ãã³æå â ã¯ã¬ã¢ããã³äžæ â è èãæªãããšããç絡çãªé£æ³ãçãŸããã®ããã
ããã2025幎ã®ã¬ãã¥ãŒè«æã§ã¯ãå¥åº·ãªäººã«ãããŠã¯ã¬ã¢ãã³ã»ã¢ããã€ãã¬ãŒãã¯å®å šã§ãããçæ¶¯ãéããŠæçãªå¹æãããããå¯èœæ§ãããããšãæç¢ºã«è¿°ã¹ãããŠããã®ãããç ç©¶è ã®Kreiderã¯ãã¯ã¬ã¢ãã³è£å ã¯å®å šã§ãããçæ¶¯ã«ããã£ãŠæçã§ãããå¶éãã¹ãã§ã¯ãªãããšãŸã§äž»åŒµããŠããããã
ãã¡ãããæ¢åã®è çŸæ£ããã人ã¯å»åž«ã«çžè«ããã®ã倧åæããããããå¥åº·ãªè èãæã€äººãã¯ã¬ã¢ãã³ãé©éæåããããšã«é¢ããŠã¯ã倧éã®ç ç©¶ããŒã¿ãå®å šæ§ãæ¯æããŠããã®ããã
ð§žãè èã«æªãã£ãŠèããŠé¿ããŠã人ããã£ãããããã ããã
ð»ââïžãïŸïœ«ïŸïœ«ãéåžžã«å€ãããããããç§åŠçæ ¹æ ãèŠãã°ãã¯ã¬ã¢ãã³ã»ã©ã³ã¹ãã®è¯ããµããªã¯ä»ã«èŠã€ãã«ããã®ããã1æ¥3ã5gã®æåã§ãçåã骚ãèªç¥æ©èœããšãã«ã®ãŒä»£è¬ã«å¹ åºãäœçšããããããäŸ¡æ Œã¯å®ããLongevityãµããªã®çéãšåŒãã§å·®ãæ¯ããªãã®ãããðã
ð»ââïžð 7ã€ã®åžžèã¢ããããŒããŸãšã
ð§žãããããŸã¡ãããå šéšã€ãªãã£ãŠããã ããæŽ»æ§é žçŽ ãæªè ãããªããŠã·ã°ãã«ã§ãã ãããã¿ãã³Cã®å€§éæåããã®ã·ã°ãã«ãéªéããŠãããŒããããéåã¯ãã«ãã·ã¹ã®é ç¹ãè¶ ãã¡ãã£ãŠãã¯ã¬ã¢ãã³ã¯çèã ããããªãè³ãå®ã£ãŠâŠã
ð»ââïžãïŸïœ¯ïŸïœ°ãããã£ããå®ç§ãªèŠçŽããïŒ ããã7ã€ã®åžžèã¢ããããŒãã«éåºããã¡ãã»ãŒãžã¯ã²ãšã€ãªã®ããã”äœã¯æ ãè ã§ã¯ãªããé©å¿ã®å€©æã§ãã”ãšããããšãããé©åºŠãªã¹ãã¬ã¹ãäžããã°äœã¯èªã匷ããªãä»çµã¿ãæã£ãŠããããã®ä»çµã¿ãä¿¡ããŠãéªéããªãããšããããããããããªãããããèªç¶ã®é£äºãå°éããç§åŠçæ ¹æ ã®ããæå°éã®ãµããªã§åºäžãããããããLongevityç§åŠãæããŠããã2025幎çã®å¥åº·åžžèãªã®ãããð»ââïžã£ïŸïŸïœŒïœ¯ã
ð§žãå®ç§ãæ±ããªããŠãããã ãã”ã¡ããã©ãã”ãç¶ãããããã ãã§ãããã ã
ð»ââïžããã®”ã¡ããã©ãã”ãèŠã€ããããã®ç§åŠããLongevityãªã®ãããâšðã
ð»ââïžð èŠãæ¹ã³ãŒããŒ ïœ 7ã€ã®åžžèã¢ããããŒããšéèŠããŒã¯ãŒããèŠãããã ïœ
ð ãã«ãã·ã¹ïŒHormesisïŒã®èŠãæ¹
èŠãæ¹â ïŒããã«ïŒã»ã©ããïŒãã·ã³ïŒèº«ãã·ã³ïŒäŒžã°ãïŒã â ã»ã©ããã¹ãã¬ã¹ã身äœãæé·ããããå€ããããšçå°ãã»ã€ããïŒãã¡ãŒãžïŒã
èŠãæ¹â¡ïŒéæ¹åããã¯ïŒïŒããã«åã«ãŒã = éïŒãã«ïŒã鳎ããã®ã¯ã¡ããã©ããåå æžã â 匱ããããé³ãåºãªãã匷ããããéãå£ãããçãäžãæé©ã
ð PGC-1αïŒããã³ã³ããªã¢æ°çã®åžä»€å¡ïŒã®èŠãæ¹
èŠãæ¹â ïŒãP(ãã¯ãŒ)G(ã²ãã)C-1α(äžçª)ã â ããã³ã³ããªã¢ã®ãã¯ãŒãã²ããããããã®äžçªã®åžä»€å¡ã
èŠãæ¹â¡ïŒéæ¹åããã¯ïŒïŒããã¿ãã³Cã®å€§éæåãPGC-1αã”å°ã蟌ãã”ã â ãCã§å°ããPGCããšèŠãããæé žåãµããªããã®åžä»€å¡ã®æŽ»æ§åã劚ããã
ð ãã¿ãã³CïŒEåé¡ïŒéåååŸã®é«çšéãµããªïŒ
èŠãæ¹â ïŒãC(æ¶ã)E(ãšãã«ã®ãŒé©å¿)ã â é«çšéã®CãšEã¯ãšãã«ã®ãŒé©å¿ã®ã·ã°ãã«ãæ¶ããŠããŸãã
èŠãæ¹â¡ïŒéæ¹åããã¯ïŒïŒãç«çœå ±ç¥åšïŒROSïŒãåã£ããé¿é£èšç·ŽïŒé©å¿ïŒããã£ã³ã»ã«ã â ãã¿ãã³CEã¯å ±ç¥åšã®é»æ± ïŒROSä¿¡å·ïŒãæããŠããŸãè¡çºã
ð ã¯ã¬ã¢ãã³ã®Longevity广ã5ã€ã®ããã
ããããã«ãïŒçèïŒããããããïŒèšæ¶ïŒãããããïŒçåâ転åäºé²ïŒããããã®ãïŒæ©èœïŒéªšå¯åºŠã»è¡ç³ïŒããããã ããããïŒç©¶æ¥µã®å®å šæ§ïŒ
èŠãæ¹ïŒãã¯ã¬ã¢ãã³ã¯”æ°”ãé ã5ã€ã®”ã”ã
éæ¹åããã¯ïŒãCK = Creatine Kinase = “C(ã¡ãããš)K(å¹ã)”ã â ã¯ã¬ã¢ãã³ãããŒãŒã·ã¹ãã ã现èã®ãšãã«ã®ãŒå¹çãæé©åããã¡ãããšå¹ããã®CKã
ð éåãã«ãã·ã¹ã®æé©ãŸãŒã³
èŠãæ¹â ïŒããŸãŒã³2 = äºïŒã«ïŒãã«ãããŒã¹ã â äŒè©±ã§ããã«ãã«ãããŒã¹ããŸãŒã³2æé žçŽ ã
èŠãæ¹â¡ïŒéæ¹åããã¯ïŒïŒã鱿«æŠå£« vs æ¯æ¥å µå£« â “ãŸ(æ¯æ¥)ã(ãã¡ã°ã)ã«(ã«)ã¡(å)” = “æ¯æ¥ãäžçªã®å”ã
ð éèŠè«æãšå¹Žå·
Paulsen et al., 2014 â ãã¿ãã³CïŒEããã¬ãŒãã³ã°é©å¿ãé»å®³ èŠãæ¹ïŒã14ïŒããŒãïŒããããªãã â 2014幎ã«ããã¿ãã³CEãµããªãããªãããšå€æ
Radak et al., 2005 â éåãã«ãã·ã¹ã®åæå± èŠãæ¹ïŒã05ïŒãããïŒãã«ãã·ã¹ã â 2005幎ã«ãã«ãã·ã¹é©åœãèµ·ããã
López-OtÃn et al., 2023 â ãããã«ãã·ã¹æŠå¿µã®Hallmarksçµ±å èŠãæ¹ïŒã23ïŒã«ãããïŒãããïŒäžãšïŒãã«ãã·ã¹ã â 2023幎ã«ãå ããããããã«ãã·ã¹ãå ¬èªãã
ð»ââïžâš 以äžãLongevityç§åŠãèŠã7ã€ã®åžžèãå®å šè§£èª¬ããã£ãããã倧åãªã®ã¯”ãããããªãåæ°”ãš”ç¶ããç¥æµ”ãªã®ãããä»å€ããããæ±ããŠãã£ããç ãã®ããããé©åºŠãªã¹ãã¬ã¹ãšååãªå埩ãããããã«ãã·ã¹ã®æããªã®ããããã®ðð»ââïžð€
ð ãPRãçŸããæªæ¥ãžã®æè³ïŒå¿ããæ¹åãFXã·ã°ãã«é ä¿¡
çŸå®¹ã«ãéããããããã«ãå°æ¥ã®èªåãžã®æè³ã倧åãå¿ããçŸå®¹é¢ä¿è ã«ã人æ°ã®ãåãåãã ããã·ã°ãã«é ä¿¡ã§ãã¹ããŒãã«è³ç£åœ¢æããŸãããïŒ
- ð¥ äžåºŠãã3,980åïœããã·ã°ãã«ãæ°žä¹ ååŸïŒ
- ð è²·ãåãäŸ¡æ Œã ããå®å¿ïŒè¿œå æéäžåãªã
- ð¯ æé¡ãããªãããè§£çŽã®å¿é ãŒãïŒ
âš ã¹ããŒãæè³è¡ïŒå¿ãã女æ§ã®ããã®ã·ã°ãã«æè³è¡ â€